Sodium (±)‐5‐bromo‐2‐(α‐hydroxypentyl) benzoate ameliorates pressure overload‐induced cardiac hypertrophy and dysfunction through inhibiting autophagy

Sodium (±)‐5‐bromo‐2‐(a‐hydroxypentyl) benzoate (generic name: brozopine, BZP) has been reported to protect against stroke‐induced brain injury and was approved for Phase II clinical trials for treatment of stroke‐related brain damage by the China Food and Drug Administration (CFDA). However, the ro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cell Mol Med
Autores principales: Wang, Bo, Shen, Deliang, Tang, Junnan, Li, Jing, Xiao, Yue, Chen, Xiuying, Cao, Chang, Han, Dongjian, Gao, Erhe, Zhao, Wen, Zhang, Jinying, Chang, Junbiao
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714213/
https://ncbi.nlm.nih.gov/pubmed/31222939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14468
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares